What is Inspire Medical Systems Inc Quarterly Revenue?

Inspire Medical Systems Inc Quarterly Revenue Inspire Medical Systems Inc Jun-2026 Quarterly Revenue is $201 Million which is growth of -7.6% YoY.

What is Inspire Medical Systems Inc Quarterly Net Profit?

Inspire Medical Systems Inc Quarterly Net Profit Inspire Medical Systems Inc Jun-2026 Quarterly Net Profit is $0 Million which is growth of 108.7% YoY.

What is Inspire Medical Systems Inc Annual Revenue?

Inspire Medical Systems Inc Annual Revenue Inspire Medical Systems Inc Dec-2025 Annual Revenue is $912 Million which is growth of 13.6% YoY.

What is Inspire Medical Systems Inc Annual Net Profit?

Inspire Medical Systems Inc Annual Net Profit Inspire Medical Systems Inc Dec-2025 Annual Net Profit is $145 Million which is growth of 171.8% YoY.

What is Inspire Medical Systems Inc Total Shareholders Fund?

Inspire Medical Systems Inc Total Shareholders Fund Inspire Medical Systems Inc Dec-2025 Total Shareholders Fund is $781 Million which is growth of 13.3% YoY.

What is Inspire Medical Systems Inc Total Assets?

Inspire Medical Systems Inc Total Assets Inspire Medical Systems Inc Dec-2025 Total Assets is $907 Million which is growth of 12.2% YoY.

What is Inspire Medical Systems Inc Book Value Per Share?

Inspire Medical Systems Inc Book Value Per Share Inspire Medical Systems Inc Book Value Per Share is $27 which is growth of 18.4% YoY.

What is Inspire Medical Systems Inc ROE?

Inspire Medical Systems Inc ROE Inspire Medical Systems Inc ROE is 0% which is growth of 0% YoY.

What is Inspire Medical Systems Inc Cash From Operating Activity?

Inspire Medical Systems Inc Cash From Operating Activity Inspire Medical Systems Inc Dec-2025 Cash From Operating Activity is $117 Million which is growth of -10.2% YoY.

What is Inspire Medical Systems Inc Net Cash Flow?

Inspire Medical Systems Inc Net Cash Flow Inspire Medical Systems Inc Dec-2025 Net Cash Flow is $-45 Million which is growth of -27.7% YoY.

Inspire Medical Systems Inc

XNYS: INSP

Mid-range Performer

Download real time

2.20(3.30%)

53.15% Fall from 52W High

867.3K

XNYS Volume

XNYS 09 Oct, 2026 5:30 PM (EDT)

Portfolio

Alert

My Notes

Inspire Medical Systems Inc quarterly and annual earnings report: results, revenue, profit, P&L, balance sheet, cash flow, financial ratios, revenue mix, peer comparison, and financial documents

View Charts

Forecaster Analyst Estimates for Inspire Medical Systems Inc share price target, revenues, EPS, net income and more

Inspire Medical Systems Inc quarterly results: revenue, profit, and P&L – 13 quarter history

Nested row level

Base Level

Reporting Type

Originally Reported

Cell Data

Actual

Table Settings

YoY & New to Old

Nested row level

Base Level

Export

NEGATIVE
Quarterly Revenue Inspire Medical Systems Inc Jun-2026 Quarterly Revenue is $201 Million which is growth of -7.6% YoY.
POSITIVE
Quarterly Net Profit Inspire Medical Systems Inc Jun-2026 Quarterly Net Profit is $0 Million which is growth of 108.7% YoY.

Inspire Medical Systems Inc, Earnings Report - Quarterly Results, standalone, All financials are in USD Million and price data in USD
Indicator	Jun '26	Mar '26	Dec '25	Sep '25	Jun '25	Mar '25	Dec '24	Sep '24	Jun '24	Mar '24	Dec '23	Sep '23	Jun '23
SR_Q Operating Rev.	200.6	204.6	269.1	224.5	217.1	201.3	239.7	203.2	195.9	164	192.5	153.3	151.1
CostOfRevenue_Q Cost Of Rev.	29.1	27.7	36.1	31.8	34.7	30.7	36	32.4	29.8	24.8	28.1	24.4	24.3
GrossProfit_Q Gross Profit	171.5	176.9	233	192.7	182.4	170.6	203.7	170.8	166	139.3	164.5	128.9	126.8
OEXPNS_Q Operating Exp. ⌄	172	178	186.9	183.1	185.7	172.1	171.9	156.5	160.9	154.5	155.2	142.4	143.4
AdminAndSellingExpenses_Q Admin Plus Selling Exp.	147.3	152.2	162	158.9	159.5	144.3	141.5	130.4	132.1	125.6	124.1	113.3	112.6
ResearchAndDevlopmentExpenses_Q RnD Exp.	24.7	25.8	24.9	24.2	26.2	27.8	30.3	26.1	28.9	28.9	31.1	29.1	30.8
OP_Q Operating Profit	-0.5	-1.1	46.1	9.6	-3.3	-1.5	31.9	14.3	5.1	-15.2	9.3	-13.5	-16.6
NetNonOperIntIncExp_Q Net Non Operations Interest Incuding Expenses ⌄	3.7	3.7	3.9	4	4.5	5.1	5.5	5.9	5.9	5.9	5.9	5.5	4.9
Others_Q Other Interest Earned	3.7	3.7	4	4	4.5	5.1	5.6	5.9	5.9	5.9	5.9	5.5	4.9
IntExpNonOperating_Q Interest Exp. Non Operating	-	-	0.1	0		-	-	-	-	-
PBT_Q Profit Before Tax	3.1	2.4	50.3	13.6	-2.3	4.2	36.6	20.3	10.9	-9.4	15.2	-8.2	-11.7
TAX_Q Tax	2.8	13.7	-85.8	3.6	1.3	1.2	1.4	1.8	1.1	0.7	0.5	0.3	0.2
NICommonStockholders_Q Net Income Common Stockholders ⌄	0.3	-11.3	136.1	9.9	-3.6	3	35.2	18.5	9.8	-10	14.8	-8.5	-12
NP_Q Net Profit	0.3	-11.3	136.1	9.9	-3.6	3	35.2	18.5	9.8	-10	14.8	-8.5	-12
NIIncludingNoncontrollingInterests_Q Net Income Including Non controlling Interests	0.3	-11.3	136.1	9.9	-3.6	3	35.2	18.5	9.8	-10	14.8	-8.5	-12
DilutedNIAvailtoComStockholders_Q Diluted NI Avail to Com Stockholders Ann.	0.3	-11.3	136.1	9.9	-3.6	3	35.2	18.5	9.8	-10	14.8	-8.5	-12
EPS_Q Basic EPS	0	-0.4	4.7	0.3	-0.1	0.1	1.2	0.6	0.3	-0.3	0.5	-0.3	-0.4
AfterDilutedEPS_Q Diluted EPS After ExtraOrdinary	0	-0.4	4.7	0.3	-0.1	0.1	1.2	0.6	0.3	-0.3	0.5	-0.3	-0.4
SHARE_Q Number Of Shares End	28.8	28.7	28.9	29.3	29.5	29.7	29.8	29.9	29.7	29.6	29.5	29.4	29.2
NIContinuingDiscontinuedOper_Q Net Income Continuing Discontinued Operations	0.3	-11.3	136.1	9.9	-3.6	3	35.2	18.5	9.8	-10	14.8	-8.5	-12
NormalizedIncome_Q Normalized Income	0.3	-11.3	136.1	9.9	-3.6	3	35.2	18.5	9.8	-10	14.8	-8.5	-12
InterestIncome_Q Interest Income	3.7	3.7	4	4	4.5	5.1	5.6	5.9	5.9	5.9	5.9	5.5	4.9
INT_Q Interest	-	-	0.1	0		-	-	-	-	-
NetInterestIncome_Q Net Interest Income	3.7	3.7	3.9	4	4.5	5.1	5.5	5.9	5.9	5.9	5.9	5.5	4.9
EBIT_Q EBIT	-0.5	-1.1	50.4	13.6	-2.3	-1.5	54.3	14.3	5.1	-15.2	15.2	-8.2	-11.7
EBITDA_Q EBITDA	4.1	4	54.3	17.2	1.1	1.6	56.8	16.2	6.5	-14.4	16.1	-7.4	-11.1
ReconciledCostOfRevenue_Q Reconciled Cost Of Rev.	29.1	27.7	36.1	31.8	34.7	30.7	36	32.4	29.8	24.8	28.1	24.4	24.3
ReconciledDepreciation_Q Reconciled Depr.	4.6	5.1	3.8	3.7	3.4	3	2.5	1.9	1.4	0.8	0.8	0.8	0.7
ProfitLossFromContinuingOperations_Q Profit From Continuing Operations	0.3	-11.3	136.1	9.9	-3.6	3	35.2	18.5	9.8	-10	14.8	-8.5	-12
NormalizedEBITDA_Q Normalized EBITDA	4.1	4	54.3	17.2	1.1	1.6	56.8	16.2	6.5	-14.4	16.1	-7.4	-11.1

*All financials are in USD Million and price data in USD

Add metric to table

Search...

Inspire Medical Systems Inc competitor comparison and performance snapshot within industry

Inspire Medical Systems Inc annual results: revenue, profit, P&L, and margins as of Dec 2025 – 11 year history

Nested row level

Base Level

Reporting Type

Originally Reported

Cell Data

Actual

Table Settings

YoY & New to Old

CAGR Columns

Select...

Nested row level

Base Level

Export

POSITIVE
Annual Revenue Inspire Medical Systems Inc Dec-2025 Annual Revenue is $912 Million which is growth of 13.6% YoY.
POSITIVE
Annual Net Profit Inspire Medical Systems Inc Dec-2025 Annual Net Profit is $145 Million which is growth of 171.8% YoY.

Inspire Medical Systems Inc, Earnings Report - Annual Results, standalone, All financials are in USD Million and price data in USD
Indicator	CAGR 3 Yrs	CAGR 5 Yrs	TTM	Dec '25	Dec '24	Dec '23	Dec '22	Dec '21	Dec '20	Dec '19	Dec '18	Dec '17	Dec '16	Dec '15
SR_A Total Rev. Ann. ⌄	30.8%	51.2%		912	802.8	624.8	407.9	233.4	115.4	82.1	50.6	28.6	16.4	8
TotalOperatingRevenues_A Operating Rev. Ann.	30.8%	51.2%	898.7	912	802.8	624.8	407.9	233.4	115.4	82.1	50.6	28.6	16.4	8
CostOfRevenue_A Cost Of Rev. Ann.	26.3%	49.9%	124.6	133.2	123	96.6	66.1	33.3	17.6	13.6	10.1	6	3.9	2.8
GrossProfit_A Gross Profit Ann.	31.6%	51.4%	774.1	778.8	679.8	528.2	341.7	200.1	97.8	68.4	40.5	22.6	12.5	5.2
OEXPNS_A Operating Exp. Ann.	23.2%	36.4%	720	727.8	643.7	568.5	389.3	240	154	103.3	60.9	38.6	29.8	25
OP_A Operating Profit Ann.	-	-	54.1	51	36.1	-40.3	-47.6	-39.9	-56.2	-34.9	-20.4	-16	-17.3	-19.8
NetNonOperIntIncExp_A Net Non Operations Interest Incuding Expenses Ann, ⌄	72.3%	-	15.3	17.4	23.2	20.6	3.4	-2	-1	1.7	-1.4	-1.6	-1.3	-1.5
Others_A Other Interest Earned Ann.	50.8%	73.9%	15.5	17.5	23.3	20.6	5.1	0.1	1.1	3.8	1.9	0.2	0.1	0.1
IntExpNonOperating_A Interest Exp. Non Operating Ann.	-61.1%	-45.6%		0.1	0		1.7	2.1	2.1	2.1	3.3	1.8	1.3	1.6
OtherExpenses_A Other Exp. Ann.	-	-		-2.7	-0.9	-0.2	-0.1	-0.1	0.1	0	-0	0	-0	-0
PBT_A PBT Ann.	-	-	69.4	65.7	58.5	-19.9	-44.3	-42	-57.1	-33.2	-21.8	-17.5	-18.5	-21.3
TAX_A Tax Ann.	-	-	-65.7	-79.7	4.9	1.3	0.6	0.1	0.1	0
NICommonStockholders_A Net Income Common Stockholders Ann. ⌄	-	-	135	145.4	53.5	-21.2	-44.9	-42	-57.2	-33.2	-21.8	-17.5	-18.5	-21.3
NP_A Net Profit Ann.	-	-	135	145.4	53.5	-21.2	-44.9	-42	-57.2	-33.2	-21.8	-17.5	-18.5	-21.3
NIIncludingNoncontrollingInterests_A Net Income Including Non controlling Interests Ann.	-	-	135	145.4	53.5	-21.2	-44.9	-42	-57.2	-33.2	-21.8	-17.5	-18.5	-21.3
DilutedNIAvailtoComStockholders_A Diluted NI Avail to Com Stockholders Ann.	-	-	135	145.4	53.5	-21.2	-44.9	-42	-57.2	-33.2	-21.8	-17.5	-18.5	-21.3
EPS_A EPS Ann.	-	-		5	1.8	-0.7	-1.6	-1.5	-2.2	-1.4	-1.5	-1.4	-1.5	-1.7
DilutedEPS_A Diluted EPS Ann.	-	-		4.9	1.8	-0.7	-1.6	-1.5	-2.2	-1.4	-1.5	-1.4	-1.5	-1.7
SHARE_Q Number Of Shares End	0%	1.4%		28.9	29.8	29.5	28.9	27.4	27	24.1	23.4	13.5	-	-
TotalExpenses_A Total Exp. Ann.	23.6%	38.1%		861	766.7	665.1	455.5	273.2	171.6	117	71	44.6	33.7	27.8
NIContinuingDiscontinuedOper_A Net Income Continuing Discontinued Operations Ann.	-	-	135	145.4	53.5	-21.2	-44.9	-42	-57.2	-33.2	-21.8	-17.5	-18.5	-21.3
NormalizedIncome_A Normalized Income Ann.	-	-	135	145.4	53.5	-21.2	-44.9	-42	-57.2	-33.2	-21.8	-17.5	-18.5	-21.3
InterestIncome_A Interest Income Ann.	50.8%	73.9%	15.5	17.5	23.3	20.6	5.1	0.1	1.1	3.8	1.9	0.2	0.1	0.1
INT_A Interest Ann.	-61.1%	-45.6%		0.1	0		1.7	2.1	2.1	2.1	3.3	1.8	1.3	1.6
EBITDA_A EBITDA Ann.	-	-	79.6	79.8	65	-17.1	-40.7	-38.6	-54.1	-30.6	-18.1	-15.5	-17.1	-19.7
ReconciledCostOfRevenue_A Reconciled Cost Of Rev. Ann.	26.3%	49.9%	124.6	133.2	123	96.6	66.1	33.3	17.6	13.6	10.1	6	3.9	2.8
ReconciledDepreciation_A Reconciled Depr. Ann.	94.6%	77.3%	17.2	14	6.6	2.9	1.9	1.2	0.8	0.5	0.4	0.3	0.1	0.1
ProfitLossFromContinuingOperations_A Profit From Continuing Operations Ann.	-	-	135	145.4	53.5	-21.2	-44.9	-42	-57.2	-33.2	-21.8	-17.5	-18.5	-21.3
NormalizedEBITDA_A Normalized EBITDA Ann.	-	-	79.6	79.8	65	-17.1	-40.7	-38.6	-54.1	-30.6	-18.1	-15.5	-17.1	-19.7

*All financials are in USD Million and price data in USD

Add metric to table

Search...

Total Rev. Ann.

1Y CHG

13.6%

2Y CAGR

20.8%

3Y CAGR

30.8%

5Y CAGR

51.2%

7Y CAGR

51.1%

10Y CAGR

60.6%

Total Revenue Annual growth is lower than historical averages.

Net Profit Ann.

1Y CHG

171.8%

Net Profit Annual growth is lower than historical averages.

Operating Exp. Ann.

1Y CHG

13.1%

2Y CAGR

13.1%

3Y CAGR

23.2%

5Y CAGR

36.4%

7Y CAGR

42.5%

10Y CAGR

40.1%

Operating Expenses Annual Cr growth is lower than historical averages.

Inspire Medical Systems Inc balance sheet as of Dec 2025: assets, liabilities, reserves, and borrowings – 11 year history

Nested row level

Base Level

Reporting Type

Originally Reported

Cell Data

Actual

Table Settings

YoY & New to Old

CAGR Columns

Select...

Nested row level

Base Level

Export

POSITIVE
Total Shareholders Fund Inspire Medical Systems Inc Dec-2025 Total Shareholders Fund is $781 Million which is growth of 13.3% YoY.
POSITIVE
Total Assets Inspire Medical Systems Inc Dec-2025 Total Assets is $907 Million which is growth of 12.2% YoY.

Inspire Medical Systems Inc, Balance Sheet, standalone, All financials are in USD Million and price data in USD
Indicator	CAGR 3 Yrs	CAGR 5 Yrs	Dec '25	Dec '24	Dec '23	Dec '22	Dec '21	Dec '20	Dec '19	Dec '18	Dec '17	Dec '16	Dec '15
TA_A Total Assets Ann. ⌄	17.1%	26.4%	907.3	808.4	676.8	564.9	295.1	281.2	181.3	200.1	25.1	13.1	-
CA_A Total Current Assets Ann.	3.3%	16.7%	583.7	630.8	593.7	530	268.5	269.9	170.6	199.3	24.1	12.3	-
CashEquivalentsShortTermInvestments_A Cash Equivalents and Short Term Investments Ann.	-11.9%	5.6%	308.3	445.6	460.4	451.4	214.5	234.4	149.5	188.2	16.1	6.7	-
Receivables_A Change In Account Receivables Ann.	25.1%	36.7%	119.7	93.1	89.9	61.2	34.2	25.1	13.1	6.7	3.9	2.1	-
Inventories_A Inventories Ann.	130.3%	76.4%	145.3	80.1	33.9	11.9	17.2	8.5	5.8	2.7	3.7	3.4	-
OtherCurrentAssets_A Other Current Assets Ann.	23.7%	39.1%	10.4	12.1	9.6	5.5	2.7	2	2.2	1.7	0.4	0.1	-
TotalNonCurrentAssets_A Total Non Current Assets Ann.	110.3%	95.6%	323.7	177.6	83.1	34.8	26.6	11.3	10.6	0.8	1	0.9	-
NetPPE_A Net PPE Ann.	71.4%	61.4%	121.4	95.2	62.7	24.1	16.4	11.1	4	0.8	1	0.9	-
InvestmentsAndAdvances_A Investments & Advances Ann.	-	-	96.3	71	9.1		9.9	-	6.3	-	-	-	-
OtherNonCurrentAssets_A Other Non Current Assets Ann.	17.4%	144%	17.3	11.3	11.3	10.7	0.2	0.2	0.4	-	-	-	-
TotalLiabilitiesNetMinorityInterest_A Total Liabilities Net Minority Interest Ann. ⌄	22.4%	19.7%	126.2	118.7	104.3	68.9	66	51.4	41.4	36.1	23.6	19.7	-
CL_A Total Current Liabilities Ann.	16.2%	35.9%	96.1	88.5	78.1	61.2	41.3	20.7	16.9	11.2	7.2	7.3	-
PayablesAndAccruedExpenses_A Payables & Accrued Exp.s Ann.	16.2%	35.3%	93.9	86.8	78.1	59.9	31.8	20.7	16.9	11.2	7.2	4	-
CurrentDebtCapLeaseObligation_A Current Debt Cap Lease Obligation Ann.	19.2%	-	2.2	1.8	-	1.3	9.5	-	-	-	-	3.3	-
CurrentDeferredLiabilities_Q Current Deferred Liabilities	-	-	-	-	-	-	-	-	-	-	-	-	-
OtherCurrentLiabilities_A Other Current Liabilities Ann.	-	-	-	-	-	-	-	-	-	-	-	-	-
TotalNonCurrentLiabilities_A Total Non Current Liabilities Ann.	57.5%	-0.4%	30.1	30.2	26.2	7.7	24.7	30.7	24.6	24.9	16.5	12.4	-
LongTermDebtAndCapitalLeaseObligation_Q LT Debt & Capital Lease Obligation	58.7%	-0.4%	30	30	24.9	7.5	24.6	30.6	24.5	24.9	16.5	-	-
TradeandOtherPayablesNonCurrent_A Trade & Other Payables Non Current Ann.	-	-	-	-	-	-	-	-	-	-	-	-	-
TotalDeferredCreditsAndOtherNonCurrentLiabilities_A Total Deferred Credits & Other Non Current Liabilities Ann.	-	-	-	-	-	-	-	-	-	-	-	-	-
TotalShareHoldersFunds_A Total ShareHolders Funds Ann. ⌄	16.3%	27.7%	781.2	689.7	572.5	496	229.1	229.8	139.8	164	1.5	-100.8	-
EQCAP_A Equity Share Capital Ann.	16.3%	27.7%	781.2	689.7	572.5	496	229.1	229.8	139.8	164	1.5	-6.6	-
CapitalStock_A Capital Stock Ann.	-	-	0	0	0	0	0	0	0	0	0	94.1	-
RetainedEarnings_A Retained Earnings Ann.	-	-	-146.5	-291.9	-345.4	-324.3	-279.4	-237.4	-180.2	-146.9	-125.1	-107.6	-
GainsLossesNotAffectingRetainedEarnings_A Gains Losses Not Affecting Retained Earnings Ann.	-	-	0.5	0.5	0.8	-0.1	-0.1	0	0.1	-0.1			-
TotalCapitalization_A Total Capitalization Ann.	16.3%	25.1%	781.2	689.7	572.5	496	244.9	254.5	164.4	188.9	17.9	5.8	-
TangibleAssets_A Tangible Assets Ann.	16.3%	27.7%	781.2	689.7	572.5	496	229.1	229.8	139.8	164	1.5	-6.6	-
WC_A Working Capital Ann.	1.3%	14.4%	487.6	542.3	515.6	468.9	227.2	249.1	153.8	188.1	17	5
InvestedCapital_A Invested Capital Ann.	16.3%	25.1%	781.2	689.7	572.5	496	254	254.5	164.4	188.9	17.9	-85.1	-
TangibleBookValue_A Tangible Book Value Ann.	16.3%	27.7%	781.2	689.7	572.5	496	229.1	229.8	139.8	164	1.5	-100.8	-
Borrowings_A Borrowings Ann.	53.5%	1%	32.2	31.8	24.9	8.9	34.1	30.6	24.5	24.9	16.5	15.7	-
NetDebt_A Net Debt Ann.	-	-	-	-	-	-	-	-	1.7	-	7.5	9	-
ShareIssued_A Share Issued Ann.	-0.5%	1.1%	28.6	29.7	29.6	29	27.4	27.1	24.1	23.4	13.5	13.5	-
SHARE_Q Number Of Shares End	0%	1.4%	28.9	29.8	29.5	28.9	27.4	27	24.1	23.4	13.5	-	-

*All financials are in USD Million and price data in USD

Add metric to table

Search...

Total Assets Ann.

1Y CHG

12.2%

2Y CAGR

15.8%

3Y CAGR

17.1%

5Y CAGR

26.4%

7Y CAGR

24.1%

Total Assets Annual growth is lower than historical averages.

Total Current Liabilities Ann.

1Y CHG

8.6%

2Y CAGR

10.9%

3Y CAGR

16.2%

5Y CAGR

35.9%

7Y CAGR

35.9%

Total Current Liabilities Annual Cr growth is lower than historical averages.

Total ShareHolders Funds Ann.

1Y CHG

13.3%

2Y CAGR

16.8%

3Y CAGR

16.3%

5Y CAGR

27.7%

7Y CAGR

25%

Total ShareHolders Funds Annual growth is lower than historical averages.

Inspire Medical Systems Inc ROE, ROCE, book value, and debt-to-equity ratio as of Dec 2025 – 11 year history

Nested row level

Base Level

Reporting Type

Originally Reported

Cell Data

Actual

Table Settings

YoY & New to Old

CAGR Columns

Select...

Nested row level

Base Level

Export

POSITIVE
Book Value Per Share Inspire Medical Systems Inc Book Value Per Share is $27 which is growth of 18.4% YoY.
NEUTRAL
ROE Inspire Medical Systems Inc ROE is 0% which is growth of 0% YoY.

Inspire Medical Systems Inc, Ratios, standalone, All financials are in USD Million and price data in USD
Indicator	CAGR 3 Yrs	CAGR 5 Yrs	Dec '25	Dec '24	Dec '23	Dec '22	Dec '21	Dec '20	Dec '19	Dec '18	Dec '17	Dec '16	Dec '15
ROA_A RoA Ann. %	-	-	-	7.21%	-3.41%	-10.44%	-14.59%	-24.74%	-17.44%	-19.39%	-91.66%	-141.26%	-
ROE_A ROE Ann. %	-	-	-	8.48%	-3.96%	-12.38%	-18.33%	-30.96%	-21.88%	-26.38%	-	-	-
ROIC_Q ROIC %	-	-	-	4.1	1.6	-0	-0.8	-2.8	-5.5	-3.2	-21.2	-	-
OPMPCT_A OPM Ann. %	-	-	5.59%	4.49%	-6.45%	-11.67%	-17.07%	-48.72%	-42.53%	-40.28%	-56.02%	-105.03%	-247.10%
NBTO_A Inventory Turnover Ratio Ann.	-	-	-	2.2	4.2	4.5	2.6	2.5	3.2	3.2	1.7	1.2	-
ASETTO_A Asset Turnover Ann. %	-	-	-	1.1	1	1	0.8	0.5	0.4	0.5	1.5	1.3	-
WCTO_A Working Capital Turnover Ann.	28.3%	30.6%	1.9	1.5	1.2	0.9	1	0.5	0.5	0.3	1.7	3.3	-
QuickRatio_A Quick Ratio Ann.	-	-	-	6.1	7.1	8.4	6	12.5	9.7	17.5	2.8	1.2	-
CRATIO_A Current Ratio Ann.	-	-	-	7.1	7.6	8.7	6.5	13	10.1	17.9	3.4	1.7	-
IC_A Interest Coverage Ratio Ann.	-	-	-	2,658	-	-25.4	-18.7	-26	-14.7	-5.6	-9	-13.2	-12.6
LTDE_A LT Debt To Equity Ann.	-	-	-	0	0	0	0.1	0.1	0.2	0.2	11.1	-	-

*All financials are in USD Million and price data in USD

Add metric to table

Search...

Inspire Medical Systems Inc cash flow: net, operating, investing, and financing flows as of Dec 2025 – 11 year history

Nested row level

Base Level

Reporting Type

Originally Reported

Cell Data

Actual

Table Settings

YoY & New to Old

CAGR Columns

Select...

Nested row level

Base Level

Export

NEGATIVE
Cash From Operating Activity Inspire Medical Systems Inc Dec-2025 Cash From Operating Activity is $117 Million which is growth of -10.2% YoY.
NEGATIVE
Net Cash Flow Inspire Medical Systems Inc Dec-2025 Net Cash Flow is $-45 Million which is growth of -27.7% YoY.

Inspire Medical Systems Inc, Cash Flow, standalone, All financials are in USD Million and price data in USD
Indicator	CAGR 3 Yrs	CAGR 5 Yrs	Dec '25	Dec '24	Dec '23	Dec '22	Dec '21	Dec '20	Dec '19	Dec '18	Dec '17	Dec '16	Dec '15
CFO_A Cash from Operating Act. Ann. ⌄	116.1%	-	117	130.3	24.7	11.6	-20.1	-53	-32.9	-18.7	-15.8	-18	-22.3
ProfitLossFromContinuingOperations_A Profit From Continuing Operations Ann.	-	-	145.4	53.5	-21.2	-44.9	-42	-57.2	-33.2	-21.8	-17.5	-18.5	-21.3
DepreciationAmortizationDepletion_A Depreciation Amortization Depletion Ann.	94.6%	77.3%	14	6.6	2.9	1.9	1.2	0.8	0.5	0.4	0.3	0.1	0.1
DepreciationAndAmortization_A Depreciation And Amortization Ann.	94.6%	77.3%	14	6.6	2.9	1.9	1.2	0.8	0.5	0.4	0.3	0.1	0.1
DeferredTax_A Deferred Tax Ann.	-	-	-88.8	-	-	-	-	-	-	-	-	-	-
DeferredIncomeTax_A Deferred Income Tax Ann.	-	-	-88.8	-	-	-	-	-	-	-	-	-	-
EmployeesStockOptions_A ESOPs Ann.	35.8%	59.1%	130.3	116	82.5	52	26.2	12.8	6.2	1.2	0.2	0.3	0.3
OtherNonCashItems_A Other Non Cash Items Ann.	37.9%	8.4%	2.1	1.5	3.7	0.8	1.4	1.4	1.3	0.7	0.3	0.2	0.1
ChangeInWorkingCapital_A Change In Working Capital Ann.	-	-	-87.4	-37.7	-40.8	1.8	-6.9	-10.9	-6.6	0.9	0.8	0.2	-1.4
ChangeInReceivables_A Change In Receivables Ann.	-	-	-26.2	-2.6	-30.2	-27	-9.2	-11.8	-6.5	-2.8	-1.8	-0.8	-0.3
ChangeInInventory_A Change In Inventory Ann.	-	-	-65.2	-46.2	-22	5.3	-8.8	-2.7	-3.2	1	-0.3	0.6	-1.5
ChangePayablesAccruedExpense_A Change Payables Accrued Expense Ann.	-55%	-5.6%	2.4	13.5	16.2	26.3	11.8	3.2	4	4	3.2	0.3	0.5
ChangeInOtherCurrentAssets_A Change In Other Current Assets Ann.	-	-	-	-	-	-	-	-	-	-	-	-	-
ChangeInOtherCurrentLiabilities_A Change In Other Current Liabilities Ann.	-	-	-	-	-	-	-	-	-	-	-	-	-
ChangeInOtherWorkingCapital_A Change In Other Working Capital Ann.	-	-	-	-	-	-	-	-	-	-	-	-	-
CFI_A Cash from Investing Act. Ann. ⌄	-	-24.3%	21.5	-113.1	-294.8	-19.6	29.1	86.6	-43.6	-83.4	-7.6	-0.3	23.6
NetPPEPurchaseAndSale_A Net PPE Purchase & Sale Ann.	-	-	-38.5	-39.1	-23.6	-9.1	-4.7	-2.5	-2.7	-0.3	-0.4	-0.3	-0.4
PurchaseOfPPE_A Purchase Of PPE Ann.	-	-	-38.5	-39.1	-23.6	-9.1	-4.7	-2.5	-2.7	-0.3	-0.4	-0.3	-0.4
NetBusinessPurchaseAndSale_A Net Business Purchase & Sale Ann.	-	-	-	-	-	-	-	-	-	-	-	-	-
PurchaseOfBusiness_A Purchase Of Business Ann.	-	-	-	-	-	-	-	-	-	-	-	-	-
PurchaseOfInvestment_A Purchase Of Investment Ann.	-	-	-250.4	-418.6	-281.4	-10.5	-10	-52.7	-178.1	-115.5	-9
SaleOfInvestment_A Sale Of Investment Ann.	-	17%	310.4	344.6	10.3		43.8	141.8	137.3	32.3	1.8		23.9
NetOtherInvestingChanges_A Net Other Investing Changes Ann.	-	-	-	-	-	-	-	-	-	-	-	-	-
CFA_A Cash from Financing Act. Ann. ⌄	-	-	-183.5	-52.4	14	235.1	15	134.1	2	190.4	25.7	12.8	2.5
NetIssuancePaymentsOfDebt_A Net Issuance Payments Of Debt Ann.	-	-	-			-24.5	-			8	0.5		2.5
NetLongTermDebtIssuance_A Net Long Term Debt Issuance Ann.	-	-	-			-24.5	-			8	0.5		2.5
NetShortTermDebtIssuance_A Net ST Debt Issuance Ann.	-	-	-	-	-	-	-	-	-	-	-	-	-
NetCommonStockIssuance_A Net Common Stock Issuance Ann.	-	-	-175	-75		243.8		124.7		181.8	-		-
CommonStockIssuance_A Common Stock Issuance Ann.	-	-	-			243.8		124.7		181.8	-		-
CommonStockPayments_A Common Stock Payments Ann.	-	-	-175	-75	-	-	-	-	-	-	-	-	-
dividend_1Y_actual Dividend 1year	-	-
DividendPerShare_A Dividend Per Share Ann.	-	-	-	-	-	-	-	-	-	-	-	-	-
NetOtherFinancingCharges_A Net Other Financing Charges Ann.	-	-	-23	-5.2	-17.2	-0	-	-	-0.5	-	-	-	-
CashAndCashEquivalentEndOfYear_A Cash Plus Cash Eqv. End Of Year Ann.	-38.1%	-11.3%	104.8	150.2	185.5	441.6	214.5	190.5	22.9	97.3	9	6.7	12.1
NetIncDecInCashAndCashEquivalents_A Net Increase In Cash Plus Cash Eqv.s Ann.	-	-	-45	-35.3	-256.2	227.1	24	167.7	-74.4	88.3	2.3	-5.4	3.9
CashAndCashEquivalentBeginOfYear_A Cash Plus Cash Eqv. Begin Of Year Ann.	-11.2%	45.7%	150.2	185.5	441.6	214.5	190.5	22.9	97.3	9	6.7	12.1	8.3
IncomeTaxPaidSupplementalData_A Income Tax Paid Supplemental Data Ann.	-	-	-	-	-	-	-	-	-	-	-	-	-
InterestPaidSupplementalData_A Interest Paid Supplemental Data Ann.	-64.8%	-44.5%	0.1	0		2.3	1.9	1.9	2	2	1.3	1.2	1.2
CapitalExpenditure_A Capex Ann.	-	-	-38.5	-39.1	-23.6	-9.1	-4.7	-2.5	-2.7	-0.3	-0.4	-0.3	-0.4
IssuanceOfCapitalStock_A Issuance Of Capital Stock Ann.	-	-	-			243.8		124.7		181.8	25	12.4
IssuanceOfDebt_A Issuance Of Debt Ann.	-	-	-	-	-	-	-			8	0.5		9.5
RepaymentOfDebt_A Repayment Of Debt Ann.	-	-	-			-24.5	-	-	-	-		-	-7
RepurchaseOfCapitalStock_A Repurchase Of Capital Stock Ann.	-	-	-175	-75	-	-	-	-	-	-	-	-	-
FreeCashFlow_A Free Cash Flow Ann.	215.5%	-	78.5	91.1	1	2.5	-24.8	-55.5	-35.6	-18.9	-16.2	-18.3	-22.6

*All financials are in USD Million and price data in USD

Add metric to table

Search...

Cash from Operating Act. Ann.

1Y CHG

-10.2%

2Y CAGR

117.6%

3Y CAGR

116.1%

Cash from Operating Activity Annual is falling faster than historical averages.

Cash from Investing Act. Ann.

5Y CAGR

-24.3%

10Y CAGR

-0.9%

Cash from Investing Activity Annual growth is stable compared to historical averages.

Forecaster
Quarterly
Competitors/Peers
Annual
Balance Sheet
Ratios
Cash Flow

53.15% Fall from 52W High

Inspire Medical Systems Inc quarterly and annual earnings report: results, revenue, profit, P&L, balance sheet, cash flow, financial ratios, revenue mix, peer comparison, and financial documents

Inspire Medical Systems Inc - Forecaster

Forecaster Analyst Estimates for Inspire Medical Systems Inc share price target, revenues, EPS, net income and more

Inspire Medical Systems Inc - Earnings Report - Quarterly Results

Inspire Medical Systems Inc quarterly results: revenue, profit, and P&L – 13 quarter history

Quarterly Revenue Inspire Medical Systems Inc Jun-2026 Quarterly Revenue is $201 Million which is growth of -7.6% YoY.

Quarterly Net Profit Inspire Medical Systems Inc Jun-2026 Quarterly Net Profit is $0 Million which is growth of 108.7% YoY.

Inspire Medical Systems Inc - Competitors/Peers

Inspire Medical Systems Inc competitor comparison and performance snapshot within industry

Inspire Medical Systems Inc - Earnings Report - Annual Results

Inspire Medical Systems Inc annual results: revenue, profit, P&L, and margins as of Dec 2025 – 11 year history

Annual Revenue Inspire Medical Systems Inc Dec-2025 Annual Revenue is $912 Million which is growth of 13.6% YoY.

Annual Net Profit Inspire Medical Systems Inc Dec-2025 Annual Net Profit is $145 Million which is growth of 171.8% YoY.

Inspire Medical Systems Inc - Balance Sheet

Inspire Medical Systems Inc balance sheet as of Dec 2025: assets, liabilities, reserves, and borrowings – 11 year history

Total Shareholders Fund Inspire Medical Systems Inc Dec-2025 Total Shareholders Fund is $781 Million which is growth of 13.3% YoY.

Total Assets Inspire Medical Systems Inc Dec-2025 Total Assets is $907 Million which is growth of 12.2% YoY.

Inspire Medical Systems Inc - Ratios

Inspire Medical Systems Inc ROE, ROCE, book value, and debt-to-equity ratio as of Dec 2025 – 11 year history

Book Value Per Share Inspire Medical Systems Inc Book Value Per Share is $27 which is growth of 18.4% YoY.

ROE Inspire Medical Systems Inc ROE is 0% which is growth of 0% YoY.

Inspire Medical Systems Inc - Cash Flow

Inspire Medical Systems Inc cash flow: net, operating, investing, and financing flows as of Dec 2025 – 11 year history

Cash From Operating Activity Inspire Medical Systems Inc Dec-2025 Cash From Operating Activity is $117 Million which is growth of -10.2% YoY.

Net Cash Flow Inspire Medical Systems Inc Dec-2025 Net Cash Flow is $-45 Million which is growth of -27.7% YoY.